I spoke with to Allan a few weeks back to discuss the SPP and, more importantly, assays. Investors need to mindful of the steps ADD have taken to keep costs at a minimum whilst ensuring the best outcome from the exploration work that has been completed to date. Key word, exploration. ADD have no revenue, so must be frugal. Unfortunately frugality comes at the cost of time, and more recently poor sentiment, as can be seen by the share price. Small bump on the path to derisking the company, and unlocking Kabanga Jirani.
At the time of our conversation (26th October) tests on drilling samples were at being completed at both SGS Rwanda, and ALS in Jo'burg.
I think it was prepped at SGS, assayed at ALS... don't quote me on the above, but to quote Allan, "we should expect to have them back within two months" - Allan Ritchie (26th Oct 2021).
I forgot to ask about multi-element testing, given the Copper and Cobalt, but would assume it's another box ADD must tick... wouldn't that be a nice Christmas present.
- Forums
- ASX - By Stock
- ADD
- Ann: Intrusions Hosting Mineralised Sulphides
Ann: Intrusions Hosting Mineralised Sulphides, page-33
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADD (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.326M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 9137000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 8963277 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 9137000 | 0.004 |
16 | 11839589 | 0.003 |
10 | 6250000 | 0.002 |
6 | 10000000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 6963277 | 13 |
0.006 | 11843406 | 9 |
0.007 | 12409536 | 9 |
0.008 | 4372084 | 7 |
0.009 | 8652428 | 3 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
ADD (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online